Vimarsana
Biggest News Aggregation in the World

Page 3 - Under Nasdaq News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Under Nasdaq. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Under Nasdaq Today - Breaking & Trending Today

POWERFLEET ANNOUNCES RESTATEMENT OF ACCOUNTING TREATMENT OF LEGACY CONVERTIBLE PREFERRED STOCK INSTRUMENT, WHICH HAS NO ADVERSE IMPACT ON PREVIOUSLY REPORTED REVENUE, CASH FLOW OR ADJUSTED EBITDA - Vimarsana News

POWERFLEET ANNOUNCES RESTATEMENT OF ACCOUNTING TREATMENT OF LEGACY CONVERTIBLE PREFERRED STOCK INSTRUMENT, WHICH HAS NO ADVERSE IMPACT ON PREVIOUSLY REPORTED REVENUE, CASH FLOW OR ADJUSTED EBITDA

WOODCLIFF LAKE, N.J., April 5, 2024 /PRNewswire/ -- Powerfleet, Inc. today announced its intention to adjust its historical accounting treatment for the redemption premium associated with its...

POWERFLEET ANNOUNCES RESTATEMENT OF ACCOUNTING TREATMENT OF LEGACY CONVERTIBLE PREFERRED STOCK INSTRUMENT, WHICH HAS NO ADVERSE IMPACT ON PREVIOUSLY REPORTED REVENUE, CASH FLOW OR ADJUSTED EBITDA - Vimarsana News

POWERFLEET ANNOUNCES RESTATEMENT OF ACCOUNTING TREATMENT OF LEGACY CONVERTIBLE PREFERRED STOCK INSTRUMENT, WHICH HAS NO ADVERSE IMPACT ON PREVIOUSLY REPORTED REVENUE, CASH FLOW OR ADJUSTED EBITDA

/PRNewswire/ -- Powerfleet, Inc. (Nasdaq: PWFL) today announced its intention to adjust its historical accounting treatment for the redemption premium...

POWERFLEET ANNOUNCES RESTATEMENT OF ACCOUNTING TREATMENT OF LEGACY CONVERTIBLE PREFERRED STOCK INSTRUMENT, WHICH HAS NO ADVERSE IMPACT ON PREVIOUSLY REPORTED REVENUE, CASH FLOW OR ADJUSTED EBITDA - Vimarsana News

POWERFLEET ANNOUNCES RESTATEMENT OF ACCOUNTING TREATMENT OF LEGACY CONVERTIBLE PREFERRED STOCK INSTRUMENT, WHICH HAS NO ADVERSE IMPACT ON PREVIOUSLY REPORTED REVENUE, CASH FLOW OR ADJUSTED EBITDA

POWERFLEET ANNOUNCES RESTATEMENT OF ACCOUNTING TREATMENT OF LEGACY CONVERTIBLE PREFERRED STOCK INSTRUMENT, WHICH HAS NO ADVERSE IMPACT ON PREVIOUSLY REPORTED REVENUE, CASH FLOW OR ADJUSTED EBITDA

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PowerFleet, Inc. - Vimarsana News

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PowerFleet, Inc.

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PowerFleet, Inc. ("PowerFleet" or the "Company") (NASDAQ: PWFL). Such investors...

Chemomab Therapeutics : Notice and Proxy Statement with respect to the Company's annual general meeting of the shareholders (the "Meeting") to be held on August 7, 2023, describing the proposals to be voted upon at the meeting, the procedure for voting in person or by proxy at the meeting and various other details related to the meeting - Vimarsana News

Chemomab Therapeutics : Notice and Proxy Statement with respect to the Company's annual general meeting of the shareholders (the "Meeting") to be held on August 7, 2023, describing the proposals to be voted upon at the meeting, the procedure for voting in person or by proxy at the meeting and various other details related to the meeting

July 3, 2023 Dear Chemomab Therapeutics Ltd. Shareholders: We cordially...